Skip to main content

CytImmune receives $100,000 from County to help advance tumor targeted nanomedicines

By June 16, 2014News
cytimmune-logo

cytimmune-logo

Rockville-based CytImmune received $100,000 from Montgomery County’s equity investment program to help the company advance its industry-leading work in the development of tumor targeted nanomedicines.

The County’s investment was made by the Montgomery County Department of Economic Development, in conjunction with a $200,000 equity investment made by the Maryland Venture Fund, which is administered by the Maryland Department of Business and Economic Development (DBED). Both the County’s and State’s investments in CytImmune are part of a broader strategy to support the growth and development of innovative companies.

{iframe}http://www.choosemontgomerymd.com/features/cytimmune-receives-100000-from-county-to-help-advance-tumor-targeted-nanome{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.